Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Acoramidis achieves early reduction in cardiovascular death or hospitalization in transthyretin amyloid cardiomyopathy (ATTR-CM): results from the ATTRibute-CM clinical trial
Acoramidis achieves early reduction in cardiovascular death or hospitalization in transthyretin amyloid cardiomyopathy (ATTR-CM): results from the ATTRibute-CM clinical trial Alexander, K., Judge, D., Cappelli, F., Fontana, M., Garcia-Pavia, P., Grogan, M., Hanna, M., Masri, A., Maurer, M., Obici, L., Soman, P., Cao, X., Tamby, J., Siddhanti, S., Katz, L., Fox, J. C., Mahaffey, K. W. TAYLOR & FRANCIS LTD. 2024: S116-S117View details for Web of Science ID 001332706900164